David Stevens
Director/Board Member at AMPIO PHARMACEUTICALS, INC.
Net worth: 4 783 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Buchi | M | 69 | 3 years | |
| David Frank | M | 63 | 17 years | |
| Michael Martino | M | 68 | 3 years | |
| Ronald Lowy | M | 68 |
Micro-Imaging Solutions LLC
 Micro-Imaging Solutions LLC Electronics/Appliance StoresRetail Trade Micro-Imaging Solutions LLC manufactures micro digital cameras. It provides engineering development support that significantly de-risks the development of new, image-guided medical instrumentation. The company was founded by Jeffrey Adair, John G. Adair, David W. Brenman and Eric F. Dahlinger in 1994 and is headquartered in Denver, CO.
Cetya Therapeutics, Inc.
 Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | 8 years |
| Elizabeth Jobes | F | 57 | 2 years | |
| Clifford L. Hendrick | M | - |
Cetya Therapeutics, Inc.
Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | - |
| Karl J. Dakin | M | - |
Advanced Headache Intervention, Inc.
 Advanced Headache Intervention, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Headache Intervention, Inc. offers headache pain solutions. It is developing electrosurgery generator and probe for use in the therapeutic treatment of headache. The company is located in Centennial, OH | - |
| Dean Wenham | M | - |
Cetya Therapeutics, Inc.
Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ronald L. Stotish | M | 74 | 13 years | |
| Ronald Martell | M | 62 | - | |
| David Bar-Or | M | 75 | 12 years | |
| Michael E. Macaluso | M | 72 | 12 years | |
| Daniel Stokely | M | 60 | - | |
| Thomas Chilcott | M | 56 | 2 years | |
| Holli Cherevka | F | 41 | 9 years | |
| Michael Perry | M | 64 | 2 years | |
| Gregory A. Gould | M | 58 | 3 years | |
| Richard Clothier | M | 78 | 17 years | |
| Elliot Z. Entis | M | - | 20 years | |
| Donald B. Wingerter | M | 74 | 3 years | |
| Nicholas Simon | M | 67 | 6 years | |
| Mark D. McGregor | M | 82 | 3 years | |
| Richard Huber | M | 87 | 15 years | |
| Richard Giles | M | 74 | 12 years | |
| Gerald McMahon | M | 69 | 8 years | |
| Robert S. Basso | M | 79 | - | |
| Philip Coelho | M | 80 | 12 years | |
| Karen Auditore-Hargreaves | M | 71 | 6 years | |
| E. Rolland Dickson | M | 90 | 14 years | |
| John Buchanan | M | - | - | |
| Alan A. Steigrod | M | 86 | - | |
| Howard Levy | M | 70 | 2 years | |
| Anita Subba Hamilton | F | 59 | 2 years | |
| Henry C. Clifford | M | 69 | 15 years | |
| Jason Stannard | M | - | 7 years | |
| Mikheil Nanazashvili | M | 67 | - | |
| Yan Zhu | M | 60 | 1 years | |
| Laura Goldberg | F | - | 8 years | |
| Anthony Wutoh | M | - |
Cetya Therapeutics, Inc.
Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | - |
| Vadim Dubrovin | M | 42 | - | |
| Vaughan Lennox Clift | M | 62 | 6 years | |
| Joshua Disbrow | M | 49 | 3 years | |
| Cheni Kwok | M | 55 | - | |
| Robert L. de Jager | M | 82 | 2 years | |
| Caroline Loewy | F | 58 | 2 years | |
| Deborah Knobelman | M | 51 | 1 years | |
| David A. Karlin | M | 80 | 3 years | |
| Joseph Hernon | M | 64 | 2 years | |
| Eric I. Steiner | M | 57 | 8 years | |
| Gregory Weaver | M | 68 | 1 years | |
| Gary Lyons | M | 73 | 3 years | |
| Carl Samuel Goldfischer | M | 65 | 12 years | |
| Alan B. Glassberg | M | 87 | 1 years | |
| Susan Berland | F | 69 | 2 years | |
| William M. Marcus | M | 86 | 20 years | |
| Linda T. Findlay | F | 75 | - | |
| Lane Hapke | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 57 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Stevens
- Personal Network